These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872 [TBL] [Abstract][Full Text] [Related]
5. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495 [TBL] [Abstract][Full Text] [Related]
6. Rewiring the brain with cell transplantation in Parkinson's disease. Gaillard A; Jaber M Trends Neurosci; 2011 Mar; 34(3):124-33. PubMed ID: 21316770 [TBL] [Abstract][Full Text] [Related]
7. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Aponso PM; Faull RL; Connor B Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835 [TBL] [Abstract][Full Text] [Related]
8. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Isacson O; Bjorklund LM; Schumacher JM Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105 [TBL] [Abstract][Full Text] [Related]
9. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337 [TBL] [Abstract][Full Text] [Related]
10. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate. Sladek JR; Bjugstad KB; Collier TJ; Bundock EA; Blanchard BC; Elsworth JD; Roth RH; Redmond DE Cell Transplant; 2008; 17(4):427-44. PubMed ID: 18522245 [TBL] [Abstract][Full Text] [Related]
11. Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats. Jungnickel J; Kalve I; Reimers L; Nobre A; Wesemann M; Ratzka A; Halfer N; Lindemann C; Schwabe K; Töllner K; Gernert M; Grothe C Behav Brain Res; 2011 Jan; 216(1):129-35. PubMed ID: 20655334 [TBL] [Abstract][Full Text] [Related]
12. Restorative strategies for the dopaminergic nigrostriatal projection pathway. Nikkhah G Acta Neurochir Suppl; 2013; 117():79-85. PubMed ID: 23652661 [TBL] [Abstract][Full Text] [Related]
13. The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease. Armstrong RJ; Hurelbrink CB; Tyers P; Ratcliffe EL; Richards A; Dunnett SB; Rosser AE; Barker RA Exp Neurol; 2002 May; 175(1):98-111. PubMed ID: 12009763 [TBL] [Abstract][Full Text] [Related]
14. Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain. Baker KA; Mendez I J Comp Neurol; 2005 Jun; 486(4):318-30. PubMed ID: 15846787 [TBL] [Abstract][Full Text] [Related]
15. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease. Baker KA; Hong M; Sadi D; Mendez I Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641 [TBL] [Abstract][Full Text] [Related]
16. Future and current surgical therapies in Parkinson's disease. Betchen SA; Kaplitt M Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808 [TBL] [Abstract][Full Text] [Related]
17. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079 [TBL] [Abstract][Full Text] [Related]
18. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. Levy YS; Stroomza M; Melamed E; Offen D J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Glavaski-Joksimovic A; Bohn MC Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820 [TBL] [Abstract][Full Text] [Related]